Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Company Ventures is a venture capital firm founded to support early-stage technology companies, particularly in New York City. The firm operates the Grand Central Tech (GCT) residency program, which provides a year-long support system for pre-Idea founders and Seed stage teams. This program has been instrumental in helping startups navigate the complexities of building successful businesses.
Currently, Company Ventures has a portfolio of over 213 companies, collectively raising more than $4.4 billion from top-tier venture capitalists. The firm focuses on sectors such as artificial intelligence, healthcare, fintech, and SaaS, and operates with a dual model that includes both traditional venture capital investments and a no-equity residency program. The firm is based in Midtown Manhattan, at 335 Madison Ave, within a tech campus that spans over 1 million square feet.
Company Ventures has established partnerships with organizations like CUNY and NYCEDC, enhancing its credibility and reach within the New York startup ecosystem. The firm has a reputation for being a preferred co-investor alongside notable firms such as Sequoia and Y Combinator, particularly in AI and software deals.
Company Ventures invests primarily in early-stage technology companies, with a strong emphasis on artificial intelligence and data automation. The firm targets pre-seed and Seed stage investments, typically writing checks in the range of $500,000 to $1 million, with flexibility for larger amounts up to $25 million at later stages. Their investment strategy is designed to support founders in building venture-scale companies, particularly in sectors like healthcare, fintech, and SaaS.
The Grand Central Tech (GCT) residency program plays a crucial role in their investment focus, providing startups with essential resources such as technical exploration, go-to-market strategies, and talent recruitment. This community-driven approach fosters collaboration among founders and connects them with a network of experts, enhancing their chances of success. Company Ventures seeks founders who demonstrate strong leadership potential and a clear vision for their companies.
Company Ventures has a diverse portfolio of over 213 companies, with notable alumni from the Grand Central Tech program. Key portfolio companies include:
Recent investments include UnityAI, an AI co-pilot for healthcare enterprise systems, Chamber Cardio, a healthcare practice management company, and Formulary Financial, which specializes in financial software. The firm continues to actively deploy capital, focusing on pre-seed through Series A investments.
Jack Altman: Founder of Company Ventures, Jack has a background in technology and venture capital. He has led numerous successful investments in the AI and software sectors, establishing a reputation for supporting innovative startups.
To pitch to Company Ventures, founders should submit their proposals through the firm's website at companyventures.co. The pitch deck should include a clear overview of the business model, market opportunity, and team qualifications. Company Ventures does not require a warm introduction but values concise and compelling presentations.
Response times can vary, but founders can expect feedback within a few weeks. The firm encourages a straightforward approach in the pitch process.
Company Ventures operates the Grand Central Tech (GCT) residency program, which is designed to support early-stage technology companies. This program offers a no-equity, no-rent residency for startups, providing them with office space, mentorship, and access to a network of corporate partners and experts.
The GCT program runs multiple cohorts each year, with the most recent cohorts confirmed for Fall 2023, Spring 2024, and Fall 2024. Startups interested in applying can find more information on the program's website.
As of March 4, 2026, Company Ventures made a recent investment in UnityAI, an AI co-pilot for healthcare enterprise systems. Other recent investments include Chamber Cardio, a healthcare practice management company, and Formulary Financial, which specializes in financial software. The firm continues to actively deploy capital in the early-stage technology sector.
What are the investment criteria for Company Ventures?
Company Ventures focuses on early-stage technology companies, particularly in artificial intelligence, healthcare, fintech, and SaaS. They typically invest in pre-seed and Seed stage startups, looking for strong leadership and a clear vision.
How can startups apply or pitch to Company Ventures?
Startups can pitch to Company Ventures through their website at companyventures.co. They encourage founders to provide a clear overview of their business model, market opportunity, and team.
What makes Company Ventures different from other venture capital firms?
Company Ventures operates a unique dual model that includes both traditional venture capital investments and a no-equity, no-rent residency program through Grand Central Tech. This approach provides startups with essential resources and a supportive community.
What is the geographic scope of Company Ventures?
The firm primarily invests in early-stage technology companies located in North America, with a strong focus on startups based in New York City.
What is the typical check size for investments?
Company Ventures typically invests between $500,000 and $1 million in early-stage companies, with the potential for larger investments up to $25 million at later stages.
What kind of post-investment involvement does Company Ventures have?
Company Ventures provides ongoing support to its portfolio companies through the GCT residency program, which includes mentorship, access to a network of experts, and resources for growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.